Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing

•Good cell culture practice is critical in in vitro genotoxicity testing.•This initiative made stocks of mammalian cell lines available worldwide.•Cell lines L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU were deposited at cell banks.•Recommendations for handling and monitoring the cell lines are desc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mutation research 2016-10, Vol.809, p.1-15
Hauptverfasser: Lorge, E., Moore, M.M., Clements, J., O’Donovan, M., Fellows, M.D., Honma, M., Kohara, A., Galloway, S., Armstrong, M.J., Thybaud, V., Gollapudi, B., Aardema, M.J., Tanir, J.Y.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 15
container_issue
container_start_page 1
container_title Mutation research
container_volume 809
creator Lorge, E.
Moore, M.M.
Clements, J.
O’Donovan, M.
Fellows, M.D.
Honma, M.
Kohara, A.
Galloway, S.
Armstrong, M.J.
Thybaud, V.
Gollapudi, B.
Aardema, M.J.
Tanir, J.Y.
description •Good cell culture practice is critical in in vitro genotoxicity testing.•This initiative made stocks of mammalian cell lines available worldwide.•Cell lines L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU were deposited at cell banks.•Recommendations for handling and monitoring the cell lines are described.•Characteristics are reported to help the routine practice of genotoxicity testing. Good cell culture practice and characterization of the cell lines used are of critical importance in in vitro genotoxicity testing. The objective of this initiative was to make continuously available stocks of the characterized isolates of the most frequently used mammalian cell lines in genotoxicity testing anywhere in the world (‘IVGT’ cell lines). This project was organized under the auspices of the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) Project Committee on the Relevance and Follow-up of Positive Results in In Vitro Genetic Toxicity (IVGT) Testing. First, cell isolates were identified that are as close as possible to the isolate described in the initial publications reporting their use in genotoxicity testing. The depositors of these cell lines managed their characterization and their expansion for preparing continuously available stocks of these cells that are stored at the European Collection of Cell Cultures (ECACC, UK) and the Japanese Collection of Research Bioresources (JCRB, Japan). This publication describes how the four ‘IVGT’ cell lines, i.e. L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU, were prepared for deposit at the ECACC and JCRB cell banks. Recommendations for handling these cell lines and monitoring their characteristics are also described. The growth characteristics of these cell lines (growth rates and cell cycles), their identity (karyotypes and genetic status) and ranges of background frequencies of select endpoints are also reported to help in the routine practice of genotoxicity testing using these cell lines.
doi_str_mv 10.1016/j.mrgentox.2016.08.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1837301660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1383571816301140</els_id><sourcerecordid>4208049871</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-8f3b5ce15b8c9563752fdef444667216b0d645547dbc5b9befd1419da128f8b23</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi1ERT_gL1SWuHBJ8HecG6gqUKkSh7ZnK7EnK6828WI7iPLrmdVuOXDhZHv0zMzr9yXkmrOWM24-bts5b2Cp6Vcr8N0y2zLGX5ELbru-kboXr_EurWx0x-05uSxly5hgktk35Fx0pheiVxcEHuqwhCGH-BsC9bDb0ZLW7KFQrNMMPs0zIFFjWgqdUqablE6kX3d1zUD3efA1HnriQlFVQlnRx_pMK5Qal81bcjYNuwLvTucVefpy-3jzrbn__vXu5vN941XX1cZOctQeuB6t77WRnRZTgEkpZUwnuBlZMEpr1YXR67EfYQpc8T4MXNjJjkJekQ_Hufucfqy4282xHKQOC6S1OG5lJ9EuwxB9_w-6xX8vqA4pgfYwozhS5kj5nErJMLl9jvOQnx1n7hCE27qXINwhCMeswyCw8fo0fh1nCH_bXpxH4NMRAPTjZ4Tsio-weAgRTa8upPi_HX8AxHyezQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826920641</pqid></control><display><type>article</type><title>Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lorge, E. ; Moore, M.M. ; Clements, J. ; O’Donovan, M. ; Fellows, M.D. ; Honma, M. ; Kohara, A. ; Galloway, S. ; Armstrong, M.J. ; Thybaud, V. ; Gollapudi, B. ; Aardema, M.J. ; Tanir, J.Y.</creator><creatorcontrib>Lorge, E. ; Moore, M.M. ; Clements, J. ; O’Donovan, M. ; Fellows, M.D. ; Honma, M. ; Kohara, A. ; Galloway, S. ; Armstrong, M.J. ; Thybaud, V. ; Gollapudi, B. ; Aardema, M.J. ; Tanir, J.Y.</creatorcontrib><description>•Good cell culture practice is critical in in vitro genotoxicity testing.•This initiative made stocks of mammalian cell lines available worldwide.•Cell lines L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU were deposited at cell banks.•Recommendations for handling and monitoring the cell lines are described.•Characteristics are reported to help the routine practice of genotoxicity testing. Good cell culture practice and characterization of the cell lines used are of critical importance in in vitro genotoxicity testing. The objective of this initiative was to make continuously available stocks of the characterized isolates of the most frequently used mammalian cell lines in genotoxicity testing anywhere in the world (‘IVGT’ cell lines). This project was organized under the auspices of the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) Project Committee on the Relevance and Follow-up of Positive Results in In Vitro Genetic Toxicity (IVGT) Testing. First, cell isolates were identified that are as close as possible to the isolate described in the initial publications reporting their use in genotoxicity testing. The depositors of these cell lines managed their characterization and their expansion for preparing continuously available stocks of these cells that are stored at the European Collection of Cell Cultures (ECACC, UK) and the Japanese Collection of Research Bioresources (JCRB, Japan). This publication describes how the four ‘IVGT’ cell lines, i.e. L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU, were prepared for deposit at the ECACC and JCRB cell banks. Recommendations for handling these cell lines and monitoring their characteristics are also described. The growth characteristics of these cell lines (growth rates and cell cycles), their identity (karyotypes and genetic status) and ranges of background frequencies of select endpoints are also reported to help in the routine practice of genotoxicity testing using these cell lines.</description><identifier>ISSN: 1383-5718</identifier><identifier>EISSN: 1879-3592</identifier><identifier>EISSN: 1873-135X</identifier><identifier>DOI: 10.1016/j.mrgentox.2016.08.001</identifier><identifier>PMID: 27692294</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>3.7.2C ; Animals ; Cell culture ; Cell Culture Techniques - standards ; Cell growth ; Cells ; Cells, Cultured ; CHL/IU ; CHO Cells ; CHO-WBL ; Cricetulus ; Cytotoxicity ; DNA Damage - drug effects ; Dose-Response Relationship, Drug ; Genetic testing ; Genotoxicity ; Humans ; L5178Y TK ; Lymphocytes - cytology ; Lymphocytes - drug effects ; Lymphocytes - metabolism ; Lymphoma - drug therapy ; Lymphoma - metabolism ; Lymphoma - pathology ; Mammals ; Mice ; Mutagenicity Tests - standards ; Mutagens - toxicity ; Reference Standards ; Spectral Karyotyping ; TK6 ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>Mutation research, 2016-10, Vol.809, p.1-15</ispartof><rights>2016 The Authors</rights><rights>Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV Oct 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-8f3b5ce15b8c9563752fdef444667216b0d645547dbc5b9befd1419da128f8b23</citedby><cites>FETCH-LOGICAL-c477t-8f3b5ce15b8c9563752fdef444667216b0d645547dbc5b9befd1419da128f8b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.mrgentox.2016.08.001$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27692294$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lorge, E.</creatorcontrib><creatorcontrib>Moore, M.M.</creatorcontrib><creatorcontrib>Clements, J.</creatorcontrib><creatorcontrib>O’Donovan, M.</creatorcontrib><creatorcontrib>Fellows, M.D.</creatorcontrib><creatorcontrib>Honma, M.</creatorcontrib><creatorcontrib>Kohara, A.</creatorcontrib><creatorcontrib>Galloway, S.</creatorcontrib><creatorcontrib>Armstrong, M.J.</creatorcontrib><creatorcontrib>Thybaud, V.</creatorcontrib><creatorcontrib>Gollapudi, B.</creatorcontrib><creatorcontrib>Aardema, M.J.</creatorcontrib><creatorcontrib>Tanir, J.Y.</creatorcontrib><title>Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing</title><title>Mutation research</title><addtitle>Mutat Res</addtitle><description>•Good cell culture practice is critical in in vitro genotoxicity testing.•This initiative made stocks of mammalian cell lines available worldwide.•Cell lines L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU were deposited at cell banks.•Recommendations for handling and monitoring the cell lines are described.•Characteristics are reported to help the routine practice of genotoxicity testing. Good cell culture practice and characterization of the cell lines used are of critical importance in in vitro genotoxicity testing. The objective of this initiative was to make continuously available stocks of the characterized isolates of the most frequently used mammalian cell lines in genotoxicity testing anywhere in the world (‘IVGT’ cell lines). This project was organized under the auspices of the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) Project Committee on the Relevance and Follow-up of Positive Results in In Vitro Genetic Toxicity (IVGT) Testing. First, cell isolates were identified that are as close as possible to the isolate described in the initial publications reporting their use in genotoxicity testing. The depositors of these cell lines managed their characterization and their expansion for preparing continuously available stocks of these cells that are stored at the European Collection of Cell Cultures (ECACC, UK) and the Japanese Collection of Research Bioresources (JCRB, Japan). This publication describes how the four ‘IVGT’ cell lines, i.e. L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU, were prepared for deposit at the ECACC and JCRB cell banks. Recommendations for handling these cell lines and monitoring their characteristics are also described. The growth characteristics of these cell lines (growth rates and cell cycles), their identity (karyotypes and genetic status) and ranges of background frequencies of select endpoints are also reported to help in the routine practice of genotoxicity testing using these cell lines.</description><subject>3.7.2C</subject><subject>Animals</subject><subject>Cell culture</subject><subject>Cell Culture Techniques - standards</subject><subject>Cell growth</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>CHL/IU</subject><subject>CHO Cells</subject><subject>CHO-WBL</subject><subject>Cricetulus</subject><subject>Cytotoxicity</subject><subject>DNA Damage - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Genetic testing</subject><subject>Genotoxicity</subject><subject>Humans</subject><subject>L5178Y TK</subject><subject>Lymphocytes - cytology</subject><subject>Lymphocytes - drug effects</subject><subject>Lymphocytes - metabolism</subject><subject>Lymphoma - drug therapy</subject><subject>Lymphoma - metabolism</subject><subject>Lymphoma - pathology</subject><subject>Mammals</subject><subject>Mice</subject><subject>Mutagenicity Tests - standards</subject><subject>Mutagens - toxicity</subject><subject>Reference Standards</subject><subject>Spectral Karyotyping</subject><subject>TK6</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>1383-5718</issn><issn>1879-3592</issn><issn>1873-135X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi1ERT_gL1SWuHBJ8HecG6gqUKkSh7ZnK7EnK6828WI7iPLrmdVuOXDhZHv0zMzr9yXkmrOWM24-bts5b2Cp6Vcr8N0y2zLGX5ELbru-kboXr_EurWx0x-05uSxly5hgktk35Fx0pheiVxcEHuqwhCGH-BsC9bDb0ZLW7KFQrNMMPs0zIFFjWgqdUqablE6kX3d1zUD3efA1HnriQlFVQlnRx_pMK5Qal81bcjYNuwLvTucVefpy-3jzrbn__vXu5vN941XX1cZOctQeuB6t77WRnRZTgEkpZUwnuBlZMEpr1YXR67EfYQpc8T4MXNjJjkJekQ_Hufucfqy4282xHKQOC6S1OG5lJ9EuwxB9_w-6xX8vqA4pgfYwozhS5kj5nErJMLl9jvOQnx1n7hCE27qXINwhCMeswyCw8fo0fh1nCH_bXpxH4NMRAPTjZ4Tsio-weAgRTa8upPi_HX8AxHyezQ</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Lorge, E.</creator><creator>Moore, M.M.</creator><creator>Clements, J.</creator><creator>O’Donovan, M.</creator><creator>Fellows, M.D.</creator><creator>Honma, M.</creator><creator>Kohara, A.</creator><creator>Galloway, S.</creator><creator>Armstrong, M.J.</creator><creator>Thybaud, V.</creator><creator>Gollapudi, B.</creator><creator>Aardema, M.J.</creator><creator>Tanir, J.Y.</creator><general>Elsevier B.V</general><general>Elsevier BV</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7TM</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>SOI</scope></search><sort><creationdate>201610</creationdate><title>Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing</title><author>Lorge, E. ; Moore, M.M. ; Clements, J. ; O’Donovan, M. ; Fellows, M.D. ; Honma, M. ; Kohara, A. ; Galloway, S. ; Armstrong, M.J. ; Thybaud, V. ; Gollapudi, B. ; Aardema, M.J. ; Tanir, J.Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-8f3b5ce15b8c9563752fdef444667216b0d645547dbc5b9befd1419da128f8b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>3.7.2C</topic><topic>Animals</topic><topic>Cell culture</topic><topic>Cell Culture Techniques - standards</topic><topic>Cell growth</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>CHL/IU</topic><topic>CHO Cells</topic><topic>CHO-WBL</topic><topic>Cricetulus</topic><topic>Cytotoxicity</topic><topic>DNA Damage - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Genetic testing</topic><topic>Genotoxicity</topic><topic>Humans</topic><topic>L5178Y TK</topic><topic>Lymphocytes - cytology</topic><topic>Lymphocytes - drug effects</topic><topic>Lymphocytes - metabolism</topic><topic>Lymphoma - drug therapy</topic><topic>Lymphoma - metabolism</topic><topic>Lymphoma - pathology</topic><topic>Mammals</topic><topic>Mice</topic><topic>Mutagenicity Tests - standards</topic><topic>Mutagens - toxicity</topic><topic>Reference Standards</topic><topic>Spectral Karyotyping</topic><topic>TK6</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lorge, E.</creatorcontrib><creatorcontrib>Moore, M.M.</creatorcontrib><creatorcontrib>Clements, J.</creatorcontrib><creatorcontrib>O’Donovan, M.</creatorcontrib><creatorcontrib>Fellows, M.D.</creatorcontrib><creatorcontrib>Honma, M.</creatorcontrib><creatorcontrib>Kohara, A.</creatorcontrib><creatorcontrib>Galloway, S.</creatorcontrib><creatorcontrib>Armstrong, M.J.</creatorcontrib><creatorcontrib>Thybaud, V.</creatorcontrib><creatorcontrib>Gollapudi, B.</creatorcontrib><creatorcontrib>Aardema, M.J.</creatorcontrib><creatorcontrib>Tanir, J.Y.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><jtitle>Mutation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lorge, E.</au><au>Moore, M.M.</au><au>Clements, J.</au><au>O’Donovan, M.</au><au>Fellows, M.D.</au><au>Honma, M.</au><au>Kohara, A.</au><au>Galloway, S.</au><au>Armstrong, M.J.</au><au>Thybaud, V.</au><au>Gollapudi, B.</au><au>Aardema, M.J.</au><au>Tanir, J.Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing</atitle><jtitle>Mutation research</jtitle><addtitle>Mutat Res</addtitle><date>2016-10</date><risdate>2016</risdate><volume>809</volume><spage>1</spage><epage>15</epage><pages>1-15</pages><issn>1383-5718</issn><eissn>1879-3592</eissn><eissn>1873-135X</eissn><abstract>•Good cell culture practice is critical in in vitro genotoxicity testing.•This initiative made stocks of mammalian cell lines available worldwide.•Cell lines L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU were deposited at cell banks.•Recommendations for handling and monitoring the cell lines are described.•Characteristics are reported to help the routine practice of genotoxicity testing. Good cell culture practice and characterization of the cell lines used are of critical importance in in vitro genotoxicity testing. The objective of this initiative was to make continuously available stocks of the characterized isolates of the most frequently used mammalian cell lines in genotoxicity testing anywhere in the world (‘IVGT’ cell lines). This project was organized under the auspices of the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) Project Committee on the Relevance and Follow-up of Positive Results in In Vitro Genetic Toxicity (IVGT) Testing. First, cell isolates were identified that are as close as possible to the isolate described in the initial publications reporting their use in genotoxicity testing. The depositors of these cell lines managed their characterization and their expansion for preparing continuously available stocks of these cells that are stored at the European Collection of Cell Cultures (ECACC, UK) and the Japanese Collection of Research Bioresources (JCRB, Japan). This publication describes how the four ‘IVGT’ cell lines, i.e. L5178Y TK+/− 3.7.2C, TK6, CHO-WBL and CHL/IU, were prepared for deposit at the ECACC and JCRB cell banks. Recommendations for handling these cell lines and monitoring their characteristics are also described. The growth characteristics of these cell lines (growth rates and cell cycles), their identity (karyotypes and genetic status) and ranges of background frequencies of select endpoints are also reported to help in the routine practice of genotoxicity testing using these cell lines.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27692294</pmid><doi>10.1016/j.mrgentox.2016.08.001</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1383-5718
ispartof Mutation research, 2016-10, Vol.809, p.1-15
issn 1383-5718
1879-3592
1873-135X
language eng
recordid cdi_proquest_miscellaneous_1837301660
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 3.7.2C
Animals
Cell culture
Cell Culture Techniques - standards
Cell growth
Cells
Cells, Cultured
CHL/IU
CHO Cells
CHO-WBL
Cricetulus
Cytotoxicity
DNA Damage - drug effects
Dose-Response Relationship, Drug
Genetic testing
Genotoxicity
Humans
L5178Y TK
Lymphocytes - cytology
Lymphocytes - drug effects
Lymphocytes - metabolism
Lymphoma - drug therapy
Lymphoma - metabolism
Lymphoma - pathology
Mammals
Mice
Mutagenicity Tests - standards
Mutagens - toxicity
Reference Standards
Spectral Karyotyping
TK6
Tumor Suppressor Protein p53 - metabolism
title Standardized cell sources and recommendations for good cell culture practices in genotoxicity testing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A16%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Standardized%20cell%20sources%20and%20recommendations%20for%20good%20cell%20culture%20practices%20in%20genotoxicity%20testing&rft.jtitle=Mutation%20research&rft.au=Lorge,%20E.&rft.date=2016-10&rft.volume=809&rft.spage=1&rft.epage=15&rft.pages=1-15&rft.issn=1383-5718&rft.eissn=1879-3592&rft_id=info:doi/10.1016/j.mrgentox.2016.08.001&rft_dat=%3Cproquest_cross%3E4208049871%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826920641&rft_id=info:pmid/27692294&rft_els_id=S1383571816301140&rfr_iscdi=true